Title : Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer.

Pub. Date : 2008 Apr 1

PMID : 18381439






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We compared primary SCLC xenografts prepared from de novo human tumors with standard cell line-based xenografts in the evaluation of a novel and highly potent small molecule inhibitor of Bcl-2, ABT-737. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid BCL2 apoptosis regulator Homo sapiens